9 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18616452 | MULTISPECIFIC ANTIBODIES FOR IMMUNO-ONCOLOGY | GILL, RACHEL B | 1671 | Final Rejection | Mar 26, 2024 |
| 18592425 | ANTI-PD-L1 AND IL-2 CYTOKINES | ROONEY, NORA MAUREEN | 1641 | Non-Final OA | Feb 29, 2024 |
| 18284952 | THERAPEUTIC INHIBITORS OF GDF15 SIGNALLING | LEE, YIE CHIA | 1642 | Non-Final OA | Sep 29, 2023 |
| 18459995 | ANTIBODIES, COMBINATIONS COMPRISING ANTIBODIES, BIOMARKERS, USES & METHODS | HADDAD, MAHER M | 1641 | Final Rejection | Sep 01, 2023 |
| 18364906 | ANTIBODIES, USES & METHODS | HADDAD, MAHER M | 1641 | Final Rejection | Aug 03, 2023 |
| 18162043 | Animal Models and Therapeutic Molecules | SINGH, ANOOP KUMAR | 1632 | Final Rejection | Jan 31, 2023 |
| 17727309 | ANTI-ICOS ANTIBODIES | OUSPENSKI, ILIA I | 1644 | Non-Final OA | Apr 22, 2022 |
| 17725228 | SYNERGISTIC COMBINATIONS OF OX40L ANTIBODIES FOR THE TREATMENT OF GVHD | OUSPENSKI, ILIA I | 1644 | Non-Final OA | Apr 20, 2022 |
| 16905537 | Animal Models and Therapeutic Molecules | SINGH, ANOOP KUMAR | 1632 | Non-Final OA | Jun 18, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial